Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows stomach emptying to support sustained weight loss. Clinical trials show that participants on higher maintenance doses lose 15–22% of body weight over 68 weeks, compared to 2–3% with placebo. Understanding how dosage works—and how it's personalized—helps patients make informed decisions about their weight loss journey.
Understanding Semaglutide Dosing: Starting Low and Titrating Up
Semaglutide weight loss therapy follows a titration schedule rather than a fixed single dose. Most treatment protocols begin at 0.25 mg once weekly to allow the body to adapt and minimize side effects. Over the following weeks, the dose gradually increases in 0.25 mg increments every 1–2 weeks, depending on tolerability and clinical response. This staged approach, called dose escalation, typically reaches a maintenance range of 1.7–2.4 mg weekly by week 16–20 of treatment.
The rationale for slow titration is twofold: it allows patients to assess tolerance to appetite suppression and gastrointestinal changes, and it reduces the likelihood of discontinuing therapy due to early side effects. Research published in obesity medicine journals confirms that slower titration schedules improve adherence and patient satisfaction compared to faster dose increases. Your healthcare provider monitors weight loss progress and symptom tolerance at each step to determine the optimal maintenance dose for your individual metabolism.
How Semaglutide Dosing Compares Across Treatment Protocols
Semaglutide is available in two delivery forms for weight loss: injectable and oral formulations. Injectable semaglutide typically uses the standard weekly titration protocol described above, reaching 2.4 mg per week at maintenance. Oral semaglutide tablets follow a different escalation schedule, starting at 3 mg daily and potentially reaching 14 mg daily, because oral absorption requires higher nominal doses to achieve equivalent clinical effect. Both formulations aim for similar therapeutic outcomes when dosed correctly, though patient preference, convenience, and individual absorption patterns influence which format works best.
PlexusDx offers both compounded semaglutide injection and oral semaglutide through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality regardless of delivery method. The choice between injection and oral typically depends on patient comfort with needles, lifestyle factors, and any existing gastrointestinal conditions that might affect oral medication absorption. Your healthcare provider will discuss which option aligns with your goals and medical history during the initial consultation.
Dose Effectiveness: What the Clinical Evidence Shows
Clinical trials demonstrate a dose-response relationship with semaglutide: higher maintenance doses generally correlate with greater weight loss. In the STEP trials, patients receiving 2.4 mg weekly achieved average weight reductions of 15–22%, while those on lower maintenance doses (0.5–1.0 mg) experienced more modest results of 5–10%. However, the majority of weight loss typically occurs between weeks 8 and 24, after which the rate of loss plateaus; continuing a stable dose maintains the achieved weight loss rather than producing additional large decreases.
Not all patients require the maximum dose to achieve meaningful health benefits. Many individuals reach their personal weight loss goal at 1.0–1.7 mg weekly, at which point their provider may recommend holding that dose to avoid unnecessary side effects. The effectiveness of any semaglutide dose depends not only on the nominal amount but also on individual factors: metabolism, genetics, adherence to diet and activity, gut health, and concurrent medications. This is why personalized assessment and ongoing monitoring matter more than chasing the highest possible dose.
The Role of Genetic Insights in Personalizing Your Semaglutide Dose
Recent advances in precision medicine reveal that genetic variations influence how individuals respond to GLP-1 therapy. PlexusDx Precision Peptide Genetic Test examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—markers that predict appetite regulation capacity and metabolic response patterns. Patients with certain genetic profiles may experience faster appetite suppression at lower doses, while others may benefit from reaching higher maintenance levels to see comparable results. This genetic roadmap helps your healthcare provider tailor your starting dose and escalation pace to match your biology rather than applying a one-size-fits-all protocol.
PlexusDx maps 14 metabolic pathways and 49 peptide interactions, providing over 150 genetic insights to guide your treatment. After your first month of therapy, adding the Precision Peptide Genetic Test ($99) offers actionable data about your unique peptide sensitivity and expected response trajectory. With this information, your provider can confidently adjust your dose schedule, select between semaglutide formulations, or explore combination therapies—knowing that the recommendation is grounded in your personal genetic predispositions rather than guesswork.
Pricing and Access: Your Dose May Rise, but Your Price Won't
PlexusDx compounded semaglutide injection starts at $149 per month across all three commitment tiers, with pricing remaining flat as your dose increases during titration and maintenance. This transparent pricing model eliminates the surprise of escalating costs as treatment progresses—a common frustration with other weight loss programs. Patients can afford to reach their optimal therapeutic dose without financial barriers interrupting care continuity. The monthly flat-rate structure applies to all three commitment plans, so whether you're month-to-month, quarterly, or annually enrolled, your investment remains predictable and affordable.
PlexusDx serves all 50 states without requiring insurance coverage or membership fees, and all medications come from licensed 503A compounding pharmacies. Semaglutide injections and oral formulations are eligible for health savings accounts (HSA) and flexible spending accounts (FSA), which further reduces out-of-pocket costs for eligible patients. This accessibility model ensures that finding and maintaining your ideal semaglutide dose is not limited by geography, insurance status, or financial constraints.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss, and how quickly does it increase?
Most patients begin at 0.25 mg weekly and increase by 0.25 mg increments every 1–2 weeks, reaching maintenance doses of 1.7–2.4 mg weekly by weeks 16–20. The exact pace depends on tolerability and clinical response monitored by your healthcare provider with PlexusDx.
Is there a maximum effective dose of semaglutide, or do all patients eventually need 2.4 mg?
No. Clinical trials show that many patients achieve meaningful weight loss at 1.0–1.7 mg weekly and may not require the maximum 2.4 mg dose. Your provider determines the optimal maintenance dose based on your individual weight loss progress and side effect tolerance, not a fixed target.
Does semaglutide pricing increase as my dose goes up each month?
No. PlexusDx compounded semaglutide injection starts at $149 per month flat across all commitment tiers—your dose may increase, but your price stays the same. This transparent model ensures predictable costs throughout your titration and maintenance phases.
Can I stop increasing my dose if I'm satisfied with my weight loss at a lower level?
Yes, absolutely. Many patients reach their personal goals before reaching the maximum dose and can remain on a stable, lower maintenance dose indefinitely. Your provider will work with you to find the sweet spot where you achieve desired weight loss without unnecessary side effects.
How can genetic testing help me find my ideal semaglutide dose?
PlexusDx Precision Peptide Genetic Test examines variants like GLP1R rs6923761 and GIPR rs1800437 that predict your appetite regulation capacity and GLP-1 sensitivity. This $99 add-on after your first month reveals whether your biology favors faster response at lower doses or if you'll need higher maintenance levels, allowing your provider to personalize your titration schedule with confidence.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Semaglutide Journey: What Time of Day Should You Take It?
Does Ozempic Help with Menopause Weight Gain?